Abstract
Background: Progressive supranuclear palsy (PSP) is a neurodegenerative disorder pathologically defined by abnormal phosphorylated tau protein (4R) aggregates, with the typical finding of tufted astrocytes. It classically presents as a symmetric, poorly responsive parkinsonism associated with early falls, supranuclear palsy of vertical gaze, dysarthria, dysphagia and cognitive and behavio…